Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | SLDB | Common Stock | 6.02K | Feb 13, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Employee Stock Option (Right to Buy) | Award | $0 | +57.5K | $0.00 | 57.5K | Feb 13, 2024 | Common Stock | 57.5K | $7.85 | Direct | F2 | |
transaction | SLDB | Restricted Stock Units | Award | $0 | +28.8K | $0.00 | 28.8K | Feb 13, 2024 | Common Stock | 28.8K | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Includes 1,752 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023. |
F2 | This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. |
F3 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). |
F4 | The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |